STLNW
Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst
NASDAQ · Healthcare · Medical - Care Facilities · US
$0.05
−23.33%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 0.61x
- P/S forward
- 0.01x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.21x
- Price / sales
- 0.01x
- Price / cash flow
- 16.13x
Enterprise value
- Enterprise value
- $69.0M
- EV / sales
- 0.12x
- EV / EBITDA
- -3.58x
- EV / EBIT
- -2.64x
- Market cap
- $5.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026